Photonic Integrated Circuit (PIX) Pilot Line For Life Science Applications (PIX4LIFE)
Forskningsprojekt, 2016
– 2019
Photonics is essential in today’s life science technology. PIX4life will mature a state of the art silicon nitride (SiN) photonics pilot line for life science applications in the visible range and pave the way to make it accessible as an enabler for product development by a broad range of industrial customers. We aim at
- establishing a validated CMOS compatible SiN technology platform in the visible range for complex densely integrated photonics integrated circuits (PICs),
- developing a supply chain to integrate mature semiconductor laser sources and CMOS detector arrays with the SiN PICs on the basis of technologies that are scalable to high volume,
- establishing appropriate design kits and tools,
- demonstrating the performance of the pilot line for well-chosen life science applications in the domain of vital sensing, multispectral sources for super-resolution microscopy, cytometry and 3D tissue imaging,
- setting up the logistics for multi-project-wafer (MPW) access to the pilot line. Integrated photonics has demonstrated that optical functions can be realized in a more compact, robust and cost-effective way by integrating functionalities on a single chip. At present industrialization is limited to telecom applications at infrared wavelengths.
Deltagare
Anders Larsson (kontakt)
Chalmers, Mikroteknologi och nanovetenskap, Fotonik
Samarbetspartners
Bosch
Gerlingen-Schillerhoehe, Germany
CMOSIS
Antwep, Belgium
Interuniversitair Micro-Electronica Centrum Vzw
Leuven, Belgium
LioniX
Enschede, Netherlands
Luceda Photonics
Dendermonde, Belgium
MedLumics
Madrid, Spain
Miltenyi Biotec
Bergisch Gladbach, Germany
PhoeniX Software
Enschede, Netherlands
RWTH Aachen University
Aachen, Germany
Solmates
Enschede, Netherlands
TOPTICA Photonics
Graefelfing, Germany
University College Cork
Cork, Ireland
VLC Photonics
Valencia, Spain
XiO Photonics
Enschede, Netherlands
Finansiering
Europeiska kommissionen (EU)
Projekt-id: EC/H2020/688519
Finansierar Chalmers deltagande under 2016–2018